Cargando…
An expert consensus report on the clinical use of the Vycross(®) hyaluronic acid VYC‐25 L filler
BACKGROUND: The portfolio of hyaluronic acid (HA) fillers and the techniques of administration have evolved in recent years. The latest innovation in the Vycross(®) range was the introduction of VYC‐25L (Juvéderm Volux(®); Allergan plc), a first‐in‐class filler effective for chin and facial lower th...
Autores principales: | Segurado, María A., Urdiales‐Gálvez, Fernando, Benítez, Paula A., Carrasco, Sara, Díaz, Iratxe, Escoda, Nuria, Farollch‐Prats, Lisandro, Figueiredo, Vitor, Ortíz, Francisco, Sebastián, María Consuelo, Uva, Luís |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9292743/ https://www.ncbi.nlm.nih.gov/pubmed/34460984 http://dx.doi.org/10.1111/jocd.14398 |
Ejemplares similares
-
Efficacy of intra‐arterial thrombolytic therapy for vision loss resulting from hyaluronic acid filler embolization
por: Xu, Xiao, et al.
Publicado: (2021) -
Management of Tear Trough with Hyaluronic Acid Fillers: A Clinical-Practice Dual Approach
por: Urdiales-Gálvez, Fernando, et al.
Publicado: (2021) -
Colouring books for adults on the cancer ward
por: Rigby, Miriam, et al.
Publicado: (2016) -
COVID-19 should be recognized as an occupational disease worldwide
por: Moen, Bente E
Publicado: (2020) -
Ultrasound assessment of tissue integration of the crosslinked hyaluronic acid filler VYC‐25L in facial lower‐third aesthetic treatment: A prospective multicenter study
por: Urdiales‐Gálvez, Fernando, et al.
Publicado: (2020)